Nitric Oxide-Sensitive Acrylamide Polymer for Inflammatory Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies fail to effectively address inflammatory diseases caused by overexpression of nitric oxide, which can lead to conditions like rheumatoid arthritis, as they do not efficiently scavenge or respond to high nitric oxide levels.
Innovation Solution
A nitric oxide-sensitive acrylamide-based polymer is developed, which can be formulated into a hydrogel form, allowing for easy administration and scavenging of nitric oxide, thereby preventing or treating inflammatory diseases by reacting with nitric oxide and forming a nano-sized hydrogel that is highly hydrophilic and biocompatible.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a large quantity of nitric oxide is released in the body, then antimicrobial and anticancer action is improved, but toxic effects and inflammatory diseases worsen
Solution Approach 1:
The patent employs nitric oxide-sensitive polymers that undergo parameter changes (swelling, degradation, or conformational change) in response to nitric oxide concentration. This allows the system to respond dynamically to varying nitric oxide levels, providing therapeutic benefit when needed while avoiding toxicity at high concentrations.
Solution Approach 2:
The patent introduces nitric oxide-sensitive polymers as intermediary substances that mediate between nitric oxide and biological systems. These polymers can scavenge excess nitric oxide or deliver drugs in response to nitric oxide signals, acting as a buffer to prevent direct toxic effects while maintaining beneficial immunomodulatory actions.
2Adaptability or versatility
If conventional therapies are used for inflammatory diseases, then general treatment is provided, but they fail to effectively address diseases caused by overexpression of nitric oxide
Solution Approach 1:
The patent employs dynamic nitric oxide-sensitive polymers that can change their properties (swelling, degradation, drug release) in response to nitric oxide concentration. This dynamic response allows the therapy to adapt to the specific pathological conditions of nitric oxide-induced inflammatory diseases, providing targeted effectiveness rather than general treatment.
Solution Approach 2:
The patent uses polymers with pre-designed nitric oxide-sensitive functional groups that are prepared in advance to specifically recognize and respond to nitric oxide. This preliminary design ensures that the therapy is pre-configured to effectively address nitric oxide-induced diseases before administration, rather than relying on general treatment mechanisms.
3Power
If nitric oxide is used for pharmaceutical applications, then anticancer and antimicrobial efficacy is improved, but toxic effects worsen
Solution Approach 1:
The patent converts the harmful aspect of nitric oxide (toxicity at high concentrations) into a beneficial signaling mechanism. By designing polymers that respond to nitric oxide presence, the system uses the harmful substance as a trigger for therapeutic action, such as drug release or polymer degradation, thereby converting toxicity into a useful diagnostic and therapeutic signal.
Solution Approach 2:
The patent introduces nitric oxide-sensitive polymers as intermediary substances that mediate between nitric oxide and therapeutic agents. These polymers can scavenge excess nitric oxide to reduce direct toxicity while simultaneously triggering drug release or other therapeutic mechanisms in response to nitric oxide signals, thus protecting against harmful effects while maintaining efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nitric oxide-sensitive acrylamide-based polymer effectively scavenges nitric oxide, alleviating inflammation and treating diseases such as rheumatoid arthritis by suppressing cytokine-induced bone resorption and cell death at joints, with the added advantage of being easily administered without surgery as an injectable preparation.
Implementation Method 1
The nitric oxide-sensitive acrylamide-based polymer effectively scavenges nitric oxide, alleviating inflammation and treating diseases such as rheumatoid arthritis
Implementation Method 2
A nitric oxide-sensitive acrylamide-based polymer is developed, which can be formulated into a hydrogel form, allowing for easy administration and scavenging of nitric oxide, thereby preventing or treating inflammatory diseases by reacting with nitric oxide and forming a nano-sized hydrogel
Data Source
AI summary
The invention relates to a nitric oxide-responsive acrylamide-based polymer, and more particularly, to an acrylamide-based polymer that is produced using an acrylamide-based monomer and a nitric oxide-sensitive crosslinking agent and allows prevention or treatment of a disease or illness caused by overexpression of nitric oxide.